These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14996827)

  • 1. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
    Weinberg AD; Evans DE; Thalhofer C; Shi T; Prell RA
    J Leukoc Biol; 2004 Jun; 75(6):962-72. PubMed ID: 14996827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells.
    Huddleston CA; Weinberg AD; Parker DC
    Eur J Immunol; 2006 May; 36(5):1093-103. PubMed ID: 16541471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
    Ruby CE; Redmond WL; Haley D; Weinberg AD
    Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of CD4 T cell memory by OX40 (CD134).
    Salek-Ardakani S; Croft M
    Vaccine; 2006 Feb; 24(7):872-83. PubMed ID: 16176850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
    Ishii N; Takahashi T; Soroosh P; Sugamura K
    Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
    Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
    Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.
    Bansal-Pakala P; Jember AG; Croft M
    Nat Med; 2001 Aug; 7(8):907-12. PubMed ID: 11479622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.
    Maxwell JR; Weinberg A; Prell RA; Vella AT
    J Immunol; 2000 Jan; 164(1):107-12. PubMed ID: 10605000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
    Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA.
    Mestas J; Crampton SP; Hori T; Hughes CC
    Int Immunol; 2005 Jun; 17(6):737-47. PubMed ID: 15908450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo.
    Weatherill AR; Maxwell JR; Takahashi C; Weinberg AD; Vella AT
    Cell Immunol; 2001 Apr; 209(1):63-75. PubMed ID: 11414737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OX-40: life beyond the effector T cell stage.
    Weinberg AD; Vella AT; Croft M
    Semin Immunol; 1998 Dec; 10(6):471-80. PubMed ID: 9826580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues.
    Xie F; Wang Q; Chen Y; Gu Y; Shi Q; Ge Y; Yu G; Wu H; Mao Y; Wang X; Zhou Y; Zhang X
    Tissue Antigens; 2006 Apr; 67(4):307-17. PubMed ID: 16634867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel roles of OX40 in the allograft response.
    Demirci G; Li XC
    Curr Opin Organ Transplant; 2008 Feb; 13(1):26-30. PubMed ID: 18660703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40).
    Pippig SD; Peña-Rossi C; Long J; Godfrey WR; Fowell DJ; Reiner SL; Birkeland ML; Locksley RM; Barclay AN; Killeen N
    J Immunol; 1999 Dec; 163(12):6520-9. PubMed ID: 10586044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.
    Taylor L; Bachler M; Duncan I; Keen S; Fallon R; Mair C; McDonald TT; Schwarz H
    J Leukoc Biol; 2002 Sep; 72(3):522-9. PubMed ID: 12223520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.
    Gramaglia I; Jember A; Pippig SD; Weinberg AD; Killeen N; Croft M
    J Immunol; 2000 Sep; 165(6):3043-50. PubMed ID: 10975814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.